S. Jung

发表

CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer

Eun Ho Kim, D. Koh, Yeaseong Ryu, 2022, AntiCancer Research.

Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) Stability Contributes to YM155 Resistance in Human Gastric Cancer Cells*

E. Choi, Seung-Woo Hong, J. Moon, 2015, The Journal of Biological Chemistry.

A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer

E. Choi, Tae Won Kim, Seung-Woo Hong, 2015, Oncotarget.

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations

Do Yeon Kim, Eun Ho Kim, Tae Won Kim, 2019, British Journal of Cancer.

SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cells.

Tae Won Kim, Seung-Woo Hong, J. Moon, 2016, Molecular medicine reports.

SH 003 selectively induces p 73 ‐ dependent apoptosis in triple ‐ negative breast cancer cells

Tae Won Kim, Seung-Woo Hong, J. Moon, 2016 .

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer

S. Park, Y. Bang, Keun-Wook Lee, 2019, Gastric Cancer.

L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells.

Seung-Woo Hong, J. Moon, Jae-Sik Shin, 2016, Free radical biology & medicine.

Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells

Eun Ho Kim, Tae Won Kim, D. Koh, 2020, Investigational New Drugs.

DGG-300273, a novel WNT/β-catenin inhibitor, induces apoptotic cell death by activating ROS-BIM signaling in a Wnt-dependent manner in colon cancer cells

D. Koh, Yeaseong Ryu, Seung-Woo Hong, 2022, Investigational New Drugs.

Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity

S. Jang, Seung-Woo Hong, J. Moon, 2015, Molecular Cancer Therapeutics.

Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC.

Eun Ho Kim, Tae Won Kim, D. Koh, 2020, Biochemical and biophysical research communications.

HM43239, a Novel Small Molecule Inhibitor of FLT3, in Acute Myeloid Leukemia (AML) with and without FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1/2 Study

N. Daver, C. Jung, M. Arellano, 2020 .

HM43239, a Novel Potent Small Molecule FLT3 Inhibitor, in Acute Myeloid Leukemia (AML) with FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1 /2 Study

K. Seo, N. Daver, C. Jung, 2019, Blood.